Cel-Sci
CVM
#10616
Rank
$20.27 M
Marketcap
$1.16
Share price
-4.92%
Change (1 day)
-87.72%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2026 (TTM): -$22.2 Million USD

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$23.25 Million USD, an increase over its 2024 earnings that were of -$26.57 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$22.2 Million-4.5%
2025 -$23.25 Million-12.52%
2024 -$26.57 Million-12.41%
2023 -$30.33 Million-12.87%
2022 -$34.82 Million-3.42%
2021 -$36.05 Million13.44%
2020 -$31.78 Million11.28%
2019 -$28.56 Million179.81%
2018 -$10.21 Million-48.72%
2017 -$19.9 Million-16.23%
2016 -$23.76 Million-23.63%
2015 -$31.11 Million-5.47%
2014 -$32.91 Million198.49%
2013 -$11.03 Million
2010 -$12.87 Million
2004 -$4.35 Million12.38%
2003 -$3.87 Million-16.59%
2002 -$4.64 Million-59.28%
2001 -$11.4 Million23.17%
2000 -$9.25 Million20.12%
1999 -$7.7 Million13.24%
1998 -$6.8 Million-20%
1997 -$8.5 Million46.55%
1996 -$5.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-117,148.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.08 B-41,041.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-$0.18 Billion 665.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-$6.76 Million-69.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.27 B-10,332.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-$0.46 Billion 1,946.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$59.1 M-366.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$14.92 Million-32.79%๐Ÿ‡บ๐Ÿ‡ธ USA